Balance Sheet Account Details (Tables)

9 Months Ended

Sep. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Inventory

Inventory, net consisted of the following (in thousands):

	September 30, 2019		December 31, 2018
Work-in-process	$	1,129	$	1,907
Finished goods	781		113
Total inventory, net	$	1,910	$	2,020

Accrued Expenses

Accrued expenses consisted of the following (in thousands):

	September 30, 2019		December 31, 2018
Accrued interest expense	$	3,458	$	2,260
Accrued clinical study costs	2,793		2,430
Accrued manufacturing costs	1,685		1,823
Accrued other	1,415		1,972
Total accrued expenses	$	9,351	$	8,485